BGIL Health is a respected healthcare product and services firm operating in Sub-Saharan Africa.
Our goal is to partner with nations in Sub-Saharan Africa to successfully provide quality and affordable healthcare solutions to the population.
Rich in opportunities, Africa is home to 7 of the world's 10 fastest growing economies. Africa's economy is accelerating faster than any other.
Providing products and services to Health care Providers, Health Insurance Services, Wholesale & distribution as well as Medical Education & Training.
BGIL Health is a respected healthcare product and services firm operating in Sub-Saharan Africa. Our goal is to partner with nations in Sub-Saharan Africa to successfully provide quality and affordable healthcare solutions to the population. Our primary focus is on:
Health Service providers: Hospitals, Clinics, primary care, diagnostic services and telemedicine models.
Health Insurance, including health Maintenance Organizations (HMOs) that combine health insurance with care provision.
Healthcare products, including but not restricted to pharmaceuticals, medical supplies, vaccines and other medicinal products.
Medical education and training institutes: Nursing and paramedical schools and eLearning platforms.
To herald the viewpoint of medical experts that primary prevention and early detection is the most effective approach against illness, disease, as well as health risks associated with today's modern lifestyle.
"For low and middle income African countries to make positive strides at reducing health care costs, disease prevention rather than treatment must be the target objective. The urgent need for health authorities in Africa to raise awareness that people are better off staying healthy rather than relying on far fetched sophisticated medical technology to rescue them from a lifetime of unhealthy living can hardly be overemphasized".
S. A.Chiambah, RPh.
BGiL Health has a targeted business strategy for the African Market
A business strategy that focuses on specific countries and regions
BGiL Health has the rare ability to identify key market segments
Developed a model to forecast demand in different countries and regions
BGiL Health is a healthcare professional services firm operating in emerging and resource limited economies in Africa. The reputation of BGiL Health on the African continent is built on honest, dependable relationships our satellite partners have developed with clients.
BGiL Health has established business ties with several African countries, whose vision for a healthier Africa mimics that of BGiL Health. Our local partners have an excellent mastery of their local markets and provide exceptional assistance to our consumers. With a seasoned team of experienced and committed representatives, BGI Health has the ability to reach every country and every major city on the African continent and is familiar with the convoluted logistic difficulties faced by most African countries. The service we provide to our clientele is based on a thorough understanding of systems and processes on the African continent.
Africa is far from homogeneous and represents diverse countries, markets, communities and development stages. BGiL Health has a targeted business strategy that focuses on specific countries and regions and has the rare ability to identify key market segments and forecast demand in different countries and regions.
The BGiL Health Commitment: We are committed to bringing safe, effective, high quality and affordable healthcare products and services to patients in Africa, utilizing our experience and professional support.
The timing for private sector investment in Africa has never been better, with so many Sub-Saharan African countries recording an unbroken pattern of economic growth in the past several years. The health sector in Africa faces some real challenges, some of which are: Poor infrastructure, an acute shortage of healthcare workers and substandard quality. These challenges coupled with lack of public sector spending on health have ironically set the stage and created favorable conditions for a robust private sector involvement in healthcare.
Africa is rich in opportunities, it is home to seven out of ten of the world's fastest growing economies and the continent's economy is accelerating faster than any other.
While the South African, Nigerian and Kenyan markets provide a wider selection of investments, it is Africa's smallest countries that are posting bigger gains.
With 70 % of its population under 35, Africa will enjoy an extraordinary demographic dividend as their energy and talents drive economic growth and development.
Africa presently has a middle class that is almost as big as the entire populations of Russia and Brazil, and the continent still has the fastest growing population in the world.
With governments across Africa working to improve the business climate, there has never been a better time to invest. By investing the right way, companies will not only grow their own balance sheets but create jobs, support local businesses and strengthen local communities across the continent.
Africa has age on its side, with 200 million people between the ages of 15 and 24 and many more of them educated than past generations of young adults. Africa is expected to have the largest global workforce by 2040 and Africa's young adult population will be a boon for consumer goods and services companies as they target an underserved population.
Sanctity of contracts including permits and licenses.
Fragmented nature of the sector
Lack of transparency
Ethical concerns – Uneven ethical standards
Limited business and financial management capacity
Access to and visibility of local credible local suppliers and partners.
The African continent has 14% of the world's population but produces only 3% of the world's medicines. While the overall pharmaceutical market in sub-Saharan Africa is worth $ 3.8 billion (USD) annually, the pharmaceutical manufacturing sector in Africa contributes only 25-30 per cent of the continent's needs. The production of life-saving drugs is furthermore concentrated in very few African countries: 70% of pharmaceutical manufacturing takes place in South Africa and an additional 20% in Nigeria, Ghana and Kenya. Apart from Morocco, more than 85% of drugs sold in Africa are imported. Today no African country, whatever its size and level of economic development, is entirely self-sufficient in pharmaceuticals. This situation has created a product gap that has been filled by the counterfeit drug industry.
Counterfeit and adulterated pharmaceuticals pose a considerable threat to human health and well-being worldwide. Fake drugs often have little therapeutic value, can seriously exacerbate the illness of patients by giving them a false sense of security and can sometimes even adversely affect the user's health. Their sub-therapeutic nature also contributes to the increasing problem of drug resistance, especially to chronic infectious diseases such as malaria, tuberculosis and HIV. The World Health Organization estimates that fake drugs account for up to 50% of drug sales in Sub-Saharan Africa but only 1% in the developed world.
At BGiL Pharma we believe that the lack of access to basic generic medicines is a good reason for Sub-Saharan African nations to produce local medicines and to be less dependent from other countries. Local production can facilitate access to medicines for those in need but while the product gap still exists BGiL Pharma is committed to bringing safe, effective, high quality and affordable pharmaceuticals and prescription medicines to patients in Africa.
At BGiL Pharma we work to help people and health care institutions in Africa realize their goal of maintaining and restoring good health as well as improving quality of life. We do this by providing a steady supply of top quality and affordable pharmaceuticals.
(Video on fake drugs) - https://www.youtube.com/watch?v=3neJmHlyXOg
Good health is wealth. Besides the fact that there's an intrinsic value of health that is a human right, the economic case for investing in healthcare is robust. Experts agree that improved healthcare in Africa is essential for sustainable development. Healthier citizens are more productive, earn more, consume more, work longer, all of which have a positive impact on the Gross Domestic Product of a country. Better health also reduces the financial cost of healthcare for the family, the community, the private sector and the government.
According to consultancy firm – McKinsey, by 2016 the market for health care in Sub-Saharan Africa will be worth $35 billion, however a skills shortage is constraining it since the continent is reckoned to host a quarter of the world's disease burden but only has 3% of its medical workforce. The World Bank reckons an additional 90,000 doctors and 500,000 nurses will be needed in the next few years. The private sector has a positive role to play within the broader context of Sub-Saharan African countries health care systems by expanding access and improving quality and efficiency.
It is our mission to promote wellness, relieve suffering and to restore the health of those we serve with a commitment to excellence in everything that we do. Our goal is to offer quality care and programs that set community standards, exceed patients' expectations and are provided swiftly, with compassion and competence.
There is a huge need to improve medical laboratory services in Africa to avoid compromising patient care. Very often medical personnel are compelled to make clinical decisions on the basis of a very limited number of diagnostic tests. Rapid and accurate diagnostic testing should be available at the first consultation to enable clinicians to accurately diagnose and to avoid wasting limited resources and increasing ill health associated with initial misdiagnosis. As treatment costs for common disease conditions increase in Sub-Saharan Africa, the need to shift from presumptive and empirical management towards achievement of specific diagnosis can hardly be overemphasized.
To be the premier provider of medical laboratory services in the communities we serve. To contribute to excellent patient care by providing comprehensive, high quality laboratory testing.
BGiL Health is relentless in forging solid partnerships with global leaders in clinical services and health care products. Quite often when Western investors arrive in Africa for the very first time, they are quick to notice that their prior experience is of very limited use. As a result the expectation of many has been cut short. Some investors see the continent's uncertainty as opportunity. It is fair to say that although unreliable infrastructure plagues conventional kinds of companies, it opens the door to novel and innovative business models. Building a wide array of relationships with capable local players is the key and BGiL Health is conversant with the convoluted processes that obtain in most African countries. BGiL Health welcomes the opportunity for partnerships with entities vying to get a foothold in terrain unknown to many outsiders.
NutriStart Vitamin Company is a Canadian nutritional supplement and vitamin company. NutriStart was founded in 1997 and has developed a reputation for high quality, affordable nutritional supplements. http://nutristart.com/nutristart/
Mushroom Wisdom, Inc. (formerly Maitake Products, Inc.) is a global leader in the development, production and research of mushroom supplements. The company introduced the Maitake mushroom to America in 1991. Mushroom Wisdom brings the healthful benefits of mushrooms, backed by rigorous scientific research, to the daily routines of consumers worldwide. http://www.mushroomwisdom.com/index.php
Oxygen For Life
American Biotech Labs
Thank you for your interest in BGiL Health. Please use the form below to quickly contact us with your enquires. You can also use the contact information to your left as well.